Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Moody's upgrades Converse Bank's ratingsAraratBank participated in the WEPs regional experience-sharing workshopIDBank issues the 3rd, 4th and 5th tranches of bonds of 2025AraratBank: Special Rate for SWIFT Transfers up to EUR 20,000 IDBank Opens a New Branch at Homplex MallUcom Launches 5G Network in Abovyan and EjmiatsinCustomer Appreciation Day at IDBank AraratBank Joins BAFT Association Over AMD 12 Billion Provided by AraratBank in 2024 to Support the MSME Sector Ucom’s General Director Joined the International CirculUP! Forum to Foster Circular Innovation in Armenia IDBank Representative Joins the Editorial Board of Trade Finance Global DIALOG Organization - Partner of the “Born in Artsakh” ProgramHow to Protect Your Bank Card Data Ucom Subscribers can Benefit from 5G Network in More than 40 CountriesAmeriabank's MyInvest Platform Gains Direct Access to AMXTrader Trading System With Support of Ucom New EdPad Educational Tablet Piloted in ArmeniaAraratBank holds Annual General Meeting of ShareholdersIDBank and Henley & Partners Successfully Held the “Invest Beyond Borders: Global Mobility & Private Banking” Event in YerevanMoody's upgrades long-term deposit ratings of Unibank to B1, outlook stableKapan International Music Festival to Take Place Third Time, Welcomes World-Class Artists and Debuts in Armenia
Life

Paracetamol claimed to be ineffective against most types of pain, study claims

Paracetamol is one of the most popular drugs that people take to combat pain or fever, but it is claimed to be ineffective against most types of pain.

Scientists at Sydney's University analyzed systematic reviews of 3,570 studies that looked at the efficacy and safety of paracetamol for treating 44 types of pain conditions. Meanwhile, a single or multiple intake of a standard dose of a popular drug (0.5-1 g) is superior to placebo only for 4 painful conditions - osteoarthritis of the knee and hip joints, recovery from the craniotomy, pelvic pain, including postpartum pain, and headache voltage.

For common conditions such as migraines and headaches with colds, as well as low back pain, the evidence for the effectiveness of paracetamol was too low or inconclusive.

Scientists questioned the recommendation of taking paracetamol for pain in the lumbosacral region back in 2016 when a randomized placebo-controlled trial involving 1,652 patients found no difference between the popular pain reliever and placebo.